COLO-704

Cat.No.: CSC-C0323

Species: Human

Source: ovarian adenocarcinoma

Morphology: grows as clusters and single cells in suspension

Culture Properties: suspension

Inquire for Price

Specification
Q & A
Customer Review

Cat.No.

CSC-C0323

Description

Established from the ascites fluid stemming from the colon metastasis of a 46-year-old white woman with ovarian adenocarcinoma in 1986

Species

Human

Source

ovarian adenocarcinoma

Recommended Medium

90% RPMI-1640 + 10% h.i. FBS

Culture Properties

suspension

Morphology

grows as clusters and single cells in suspension

Karyotype

Human hyperdiploid karyotype with 22% polyploidy - 51(48-53)<2n>XX, +1, +7, +8, +8, -17, +19, +20, i(1q), der(8)t(8;?)(q21;?) - dm present in 16% cells - i(1q) is associated with ovarian carcinoma - identification confirmed

Quality Control

Mycoplasma: negative in DAPI, microbiological culture, RNA hybridization, PCR assays
Immunology: cytokeratin -, cytokeratin-7 -, cytokeratin-8 -, cytokeratin-17 -, cytokeratin-18 -, desmin -, endothel -, GFAP -, HMB-45 -, neurofilament -, vimentin +
Virus

Storage and Shipping

Frozen with 70% medium, 20% FBS, 10% DMSO at about 6 x 10^6 cells/ampoule; ship in dry ice; store in liquid nitrogen

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

How are cell culture models of ovarian cancer created?

Cell culture models of ovarian cancer are created by isolating cancer cells from patient samples or established cell lines and growing them in a suitable culture medium.

Ask a Question

Average Rating: 5.0 | 1 Scientist has reviewed this product

Reliable

Tumor cell products exhibit reliable cell survival, with the majority of cells remaining viable after thawing.

12 Oct 2022

Ease of use
After sales services
Value for money

Write your own review

You May Also Need

CM-1448Y

SuperCult® RPMI 1640 Medium

INQUIRY

CS-001Y

PremSera® FBS

INQUIRY

OC 316

Description: Species: human female 60 years old;
Tissue: ovary;
Tumor: adenocarcinoma, low differentiated;
G3 FIGO stage IV (pleural metastasis);
Derived from: ascitic fluid

Cat#: CSC-6307W INQUIRY

View Product

EFO-27

Description: Established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979; initially diploid, later tetraploid; growth in nude mice

Cat#: CSC-C0318 INQUIRY

View Product

EFO-21

Description: Established from the ascitic fluid of a 56-year-old Caucasian woman with dedifferentiated serous cystadenocarcinoma of the ovary in 1979

Cat#: CSC-C0341 INQUIRY

View Product

FU-OV-1

Description: Established post-hysterectomy from the tumor tissue of a 65-year-old Japanese woman with malignant ovarian carcinoma (stage: FIGO IIIc; histology: poorly differentiated serous papillary adenocarcinoma) in 1989

Cat#: CSC-C0477 INQUIRY

View Product

Caov-3

Description: The cells are distributed for research purposes only. The culture condition is 37℃，95% air, carbon dioxide (CO2), complete growth medium supplemented with 5% (v/v) DMSO

Cat#: CSC-C9094W INQUIRY

View Product

OVCAR-3

Description: Established in 1982 by T.C. Hamilton, et al. from the malignant ascites of a patient with progressive adenocarcinoma of the ovary.

Cat#: CSC-C9120W INQUIRY

View Product

For research use only. Not for any other purpose.